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Abstract: Mushroom irradiation has been considered a sustainable process to generate high amounts
of vitamin D2 due to the role of this vitamin for human health and of the global concerns regarding
its deficient or inadequate intake. Mushrooms are also receiving increasing interest due to their
nutritional and medicinal properties. However, there is still a knowledge gap regarding the effect
of UV irradiation on mushroom bioactive compounds. In this study, two of the most cultivated
mushroom species worldwide, Agaricus bisporus and Pleurotus ostreatus, were irradiated with UV-B,
and the effect of processing was investigated on the contents of vitamin D2 as well as on antioxidant and
antiglycation activities. UV irradiation increased vitamin D2 up to 57 µg/g d.w, which is an adequate
level for the fortification of a number of target foods. UV irradiation decreased the antioxidant
activity when measured by the Folin–Ciocalteu reagent, the 2,2-diphenyl-1-(2,4,6 trinitrophenyl)
hydrazyl radical assay and the ferric ion-reducing antioxidant power assay, but did not decrease
the mushroom’s ability to inhibit glycation of a target protein. These results open up a new area of
investigation aimed at selecting mushroom species with high nutraceutical benefits for irradiation in
order to maintain their potential properties to inhibit oxidative and glycation processes responsible
for human diseases.
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1. Introduction
Deficient and inadequate vitamin D intake (vitamin D represents both D2 and D3 forms) is a
worldwide public health issue causing both skeletal diseases and increased risk of various chronic
diseases [1]. Sources of vitamin D for humans are sunlight exposure, yielding vitamin D3; a few foods of
animal origin providing vitamin D3; and yeasts and mushrooms, providing vitamin D2. Both vitamin
D2 and D3 are metabolized in the liver to 25-hydroxyvitamin D (25(OH)D) and then in the kidneys to
1,25-dihydroxyvitamin D (1,25(OH)2D). According to the serum concentration of 25(OH)D, vitamin D
status is defined as deficient when serum 25(OH)D is lower than 25 nmol/L (10 ng/mL) and insufficient
when serum 25(OH)D is between 25 and 50 nmol/L (10–20 ng/mL). Vitamin D status can also be
assessed by validated food questionnaires [2]. Populations at risk of vitamin D deficiency are young
children, the elderly, pregnant women and non-western immigrants in Europe [1]. The occurrence of
vitamin D deficiency was found to be 48.1% in a Chinese population of preschool-aged children [3].
A large survey throughout Europe has shown that the intake of vitamin D is inadequate for 77–100%
of adults (19–64 years old) and for 55–100% of elderly adults (>64 years old) [4]. From the 2005–2016
National Health and Nutrition Examination Surveys (NHANES), the prevalence of inadequacy for
vitamin D intake among US population was found to be 95% [5].
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Despite the fact that vitamin D3 can be formed by the conversion of its precursors in the skin
upon sunlight exposure, the above-reported studies document that this process is not sufficient to
ensure appropriate levels of this vitamin. Moreover, the intake of vitamin D3 from animal-based
foods is not a proper solution because the current food systems, which are highly dependent on
animal-based food sources, are not sustainable from an environmental point of view but also from
a health and food security perspective [6]. Hence, one strategy to overcome the global demand of
vitamin D in a sustainable way is to produce this vitamin from mushroom irradiation. This way,
vitamin D can be delivered through fortified foods [7]. The amount of vitamin D2 in mushrooms is
generally low. However, mushrooms have high amounts of the vitamin D2 precursor, i.e., ergosterol.
Processes that generate vitamin D2 from ergosterol have been developed by UV irradiation on either
the fresh or dried fruit body [8]. Recent trends have tested the efficiency of vitamin D2 generation
by combining supercritical CO2 extraction with dissolution of the extract in ethanol or methanol
followed by UV irradiation [9]. Pleurotus spp. are among the basidiomycetes that can be used for
vitamin D2 generation because their cultivation can be performed on various agri-food waste at a
low cost [10,11]. Another basidiomycete of interest is Agaricus bisporus, which is the most cultivated
mushroom worldwide [12].
Mushrooms are known to have medicinal properties and interest in this food source is increasingly
expanding due to many studies that demonstrated their potential roles on human health due to
antioxidant, antitumor, antimicrobial, anti-inflammatory, immunomodulator, antiatherogenic and
hypoglycemic activities [10,11].
There is still a knowledge gap regarding the effect of UV irradiation on mushrooms’ bioactive
properties. Nevertheless, it is known that UV radiation can promote photo-oxidation via two major
routes. The first of these involves direct photo-oxidation arising from the absorption of UV radiation
by chromophores, thereby generating excited state species (singlet or triplets) or radicals as a result of
photo-ionization. The second major process involves indirect oxidation of targets via the formation
and subsequent reactions of singlet oxygen (1O2). Antioxidant enzymes that eliminate 1O2 have
not evolved. Instead, the highly reactive 1O2 can interact with potential targets by either physical
quenching or a chemical reaction. The former results in energy transfer and de-excitation of the singlet
state but no chemical change in the energy acceptor. The latter causes modification of the target and in
the initiation of radical type reactions [13]. Hence, it may be expected that UV irradiation affects the
potential ability of mushrooms to prevent cell damage.
Oxidative stress has been found to mediate cell damage, thus triggering a number of human
diseases [14]. The term is used to describe the condition of oxidative damage resulting when the
critical balance between reactive oxygen species (ROS) enzymatic and non-enzymatic generation and
antioxidant defenses (low molecular weight antioxidants, antioxidant enzymes and repair enzymes)
is unfavorable.
Moreover, carbonyl stress is another route leading to cell damage that is associated with a number
of human diseases [15]. It involves highly reactive dicarbonyl compounds that are formed mainly
through non-enzymatic protein glycation and in turn are involved in the formation of various harmful
cross-linked adducts, which are collectively called advanced glycation end-products (AGEs).
The bioactive properties of mushrooms are due to the polysaccharides, proteins, lipids and
molecules from their secondary metabolism, such as terpenoids, eritadenine, ergothioneine and
phenolic compounds [10,11,16–18]. The antioxidant activity of edible mushrooms was studied
in mice and has been associated mainly with the polysaccharide fraction, ergothioneine, and
phenolic compounds [9,10]. There is little information on the antiglycation activity of mushrooms.
In a previous study, polysaccharides isolated from Ganoderma lucidum were supplemented in
high-fat-diet/streptozotocin diabetic rats and found to decrease the level of AGEs and augment
the activities of antioxidant enzymes [19].
In this study, P. ostreatus and A. bisporus were submitted to UV irradiation and the effects of the
process on vitamin D2 content, as well as antioxidant and antiglycation properties were investigated
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to obtain overall knowledge regarding the impact of this process on the potential health benefit
of mushrooms.
2. Materials and Methods
2.1. Chemicals
Chemicals were purchased from Sigma Aldrich (Milan, Italy).
2.2. Mushrooms
P. ostreatus and A. bisporus were purchased from the market. The irradiation treatment was
performed as described previously [20]. In brief, about 10 kg of body fruits were used for each
mushroom type, cut into 4 mm slices, spread on an oven rack in a single layer and air-dried at 37 ◦C
for 48 h. During the first 24 h of air-drying, the mushrooms were irradiated using two fluorescent
lamps installed at 30 cm above the mushroom layer. In accordance to most of the previous studies
so far performed [8,12], a UV-B source was chosen for the irradiation. The lamps delivered a UV-B
(280–315 nm) irradiance of 0.4 W/m2. At the end of the process, about 1 kg of dried mushroom
was obtained from each mushroom type and the product was grinded to a fine powder using a
Thermomix TM 31 (Vorwerk Contempora S.r.l., Milan, Italy). Control P. ostreatus and A. bisporus
powders were obtained by processing mushrooms with the same drying and grinding procedure
without UV irradiation.
2.3. Determination of Vitamin D2
Vitamin D2 and ergosterol were extracted in triplicate from non-irradiated and irradiated
mushroom powders after saponification as described previously [21]. To check the recovery, preliminary
samples of mushroom powder were added with 0.1 mL of vitamin D3 (400 mg/L in methanol).
The observed recovery was always higher than 90%. Then, samples were analyzed without vitamin
D3 in order to check the possible presence of vitamin D2 photoproducts with elution times close
to that of vitamin D3 [22]. Vitamin D2 and ergosterol were identified by a previously published
procedure [23]. A Shimadzu HPLC system (Kyoto, Japan), including an LC-20 AD pump and an
SPD-M20A photodiode array detector operated by Labsolution Software, was used. The column was a
C18 Sunfire (4.6 mm × 250 mm × 5 mm, Waters, Milan, Italy) and the mobile phase was methanol:water
(95:5, v/v), at a flow rate of 1.0 mL/min. UV detection was performed at 254 nm. The retention times for
vitamin D2, vitamin D3 and ergosterol were 19.5, 20.5 and 23 min, respectively. The content of vitamin
D2, vitamin D3 and ergosterol were calculated on the basis of the calibration curve of pure compounds.
2.4. Recovery of Bioactive Fractions
Mushroom powders of P. ostreatus and A. bisporus were extracted in triplicate with cold water
(0.25 g into 5 mL) for 24 h at 4 ◦C under magnetic stirring. Then, the mixtures were centrifuged
(Centrikon T-42K, Kontron, Instruments, Milan, Italy) at 12,000 rpm for 30 min at 20 ◦C and the
supernatant was used for further characterization [24]. The ethanol-insoluble fractions were obtained
by adding 8.3 mL of 96% ethanol to 2 mL of the water extracts. The precipitate was recovered by
centrifugation (Centrikon T-42K) at 12,000 rpm for 30 min at 20 ◦C and redissolved in water for
further characterization [25]. The yield of water-soluble extracts and ethanol-insoluble precipitates
was determined by measuring the weight of dry solids after drying in a vacuum oven at 70 ◦C and
50 Torr for 18 h.
2.5. Antioxidant Activity
The Folin–Ciocalteu (FC) assay was performed on the water-soluble fractions and the
ethanol-insoluble fractions redissolved in water, as described previously [26]. A calibration curve was
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built using gallic acid. FC-reducing compounds were expressed as milligram of gallic acid equivalents
(GAE) per gram of dry fraction.
The free radical scavenging capacity of the water-soluble fractions and the ethanol-insoluble fractions
redissolved in water was evaluated using the stable 2,2-diphenyl-1-(2,4,6 trinitrophenyl) hydrazyl radical
(DPPH) as described previously [27]. Additionally, 6-hydroxy-2,5,7,8-tetramethylchroman-2-carboxylic
acid (Trolox) was used as a reference antioxidant and the results were expressed as micromoles of Trolox
equivalents (TE) per gram of dry fractions.
The ferric ion-reducing antioxidant power (FRAP) assay was performed on of the water-soluble
fractions and the ethanol-insoluble fractions redissolved in water as described previously [26].
FeSO4 was used for calibration and the results were expressed as micromoles of Fe II equivalents per
gram of dry fractions.
2.6. Antiglycation Activity Using Bovine Serum Albumin (BSA)/Fructose Model Systems
The antiglycation activity was determined on the water-soluble fractions and the ethanol-insoluble
fractions redissolved in water, as described previously [28]. The reaction mixture was prepared by
adding 100 µL of sample extracts or standard diluted in water, 900 µL of 200 mM potassium phosphate
buffer, pH 7.4 with 0.02% sodium azide, 300 µL of bovine serum albumin (BSA) solution (50 mg/mL
of BSA in phosphate buffer) and 300 µL of fructose solution (1.25 M fructose in phosphate buffer).
A BSA solution (blank sample) and control reaction without sample addition were prepared in parallel.
The mixtures were incubated at 37 ◦C for 3 days in the dark and then analyzed for fluorescence on a
Perkin-Elmer LS 55 Luminescence Spectrometer (Perkin-Elmer, Milan, Italy) with an excitation/emission
wavelength pair of 350/420 nm and 5 nm slit width, read against phosphate buffer. Aminoguanidine
was used as a positive control. For each sample extract, 3–4 dilutions were assessed in duplicate.
Dose–response curves were built reporting % inhibition of BSA glycation as a function of sample or
standard concentration. The results were expressed as milligrams of aminoguanidine equivalents (AG)
per gram of dry fractions.
2.7. Statistical Analysis of Data
Experimental data were analyzed using one-way ANOVA with the least significant difference
(LSD) as a multiple range test using Statgraphics 5.1 (STCC Inc., Rockville, MD, USA). These results
are reported as the average ± standard error (SE).
3. Results and Discussion
3.1. The Effect of Mushroom Irradiation on Vitamin D2 Content
Initial content of vitamin D2 was low in both commercial mushrooms considered. This result
is consistent with previous studies and could be associated with the conditions used for industrial
cultivation of mushrooms that generally occurs with low exposure to sunlight [8,12]. UV irradiation
led to an increase in vitamin D2 content from 3.1 to 37 µg/g d.w. and from 0.3 to 57 µg/g d.w. in
P. ostreatus and A. bisporus, respectively (Table 1). The initial contents of ergosterol were 3600 and
5700 µg/g d.w. in P. ostreatus and A. bisporus, respectively (Table 1). These values fall in the range
previously reported [29] and remained high after the generation of significant amounts of vitamin D2.
This result may suggest that upon UV irradiation. the residual amount of ergosterol is still relevant for
drug development and could contribute to the health-promoting effects of mushrooms [30].
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Table 1. Vitamin D2 and ergosterol content in non-irradiated and UV-irradiated mushrooms a.
Mushroom Vitamin D2 µg/g d.w Ergosterol µg/g d.w.
P. ostreatus 3.1 c ± 0.1 3600 c ± 400
P. ostreatusUV 37 b ± 0.1 3200 c ± 300
A. bisporus 0.31 d ± 0.1 5700 a ± 300
A. bisporusUV 57 a ± 0.1 4800 b ± 300
a Values are average ± SE. Different letters in the same column (a–d) indicate significant differences among samples
(LSD, p < 0.05).
The contents of vitamin D2 obtained were in the recovery range described by previous studies,
i.e., from 3.9 to 741 µg/g d.w. for A. bisporus and from 27.89 to 239.67 µg/g d.w. for P. ostreatus,
respectively [8]. In the present study, no vitamin D2 photoproducts were detected (Figure 1).
According to [22], irradiation of P. ostreatus led to significant formation of vitamin D2, tachysterol2 and
lumysterol2, but the conditions applied were different from those used in the present study and the
amount of vitamin D2 produced was 141.2 mg/kg, i.e., higher than those observed in the present study.
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Figure 1. HPLC profile of the n-hexane extract of irradiated P. ostreatus powder. 1. Vitamin D2; 2. ergosterol.
The yield of vitamin D2 formation upon irradiation was previously found to depend on conditions
that can be controlled during processing, such as the light source, the distance between the lamp and
the mushroom, temperature and the duration of the irradiation. However, the yield also depends
on factors that cannot be controlled, such as the shape of mushroom, which conditions the surface
exposed to light and the moisture levels, that varies during drying [8]. The final powder obtained after
irradiation can be standardized for vitamin D2 content by mixing the treated powder with untreated
powder. Hence, considering a target final value for vitamin D2 of 40 µg/g d.w., a simulation was
conducted to calculate the amount of irradiated powder that could be necessary to fortify vehicle foods
in order to achieve health benefits (Table 2).
To perform this simulation, three studies were considered to define the most appropriate target
foods and fortification levels, namely, a study in line with the regulation dealing with vitamin D
fortification in the United States and Canada [31], a study considering the European regulation
scenario on vitamin D fortification [32] and a study aimed at exploring food matrices for vitamin
D fortification in low/lower-middle income countries [33]. These latter studies defined somewhat
different fortification strategies due to different dietary habits and needs of the populations involved
and to different regulations of the countries of interest. In any case, it can be observed that very low
fortification levels of mushroom powder, in the range 0.03 to 0.38 g/100 g of food, could lead to the
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target fortification level, thus confirming the potential role of irradiation technology in increasing the
intake of vitamin D (Table 2).
Table 2. Modelled formulations of foods with irradiated mushroom powder to achieve a target level of
vitamin D2 a.
Food Category
Target Level for
Vitamin D µg/100 g
Food
Reference
Amount of UV-Irradiated
Mushroom Powder
g/100 Food
Ready-to-eat breakfast cereals 8.75 [31] 0.22
Milk 1.05 [31] 0.03
Yogurt 2.225 [31] 0.06
Margarine 8.275 [31] 0.21
Edible oil 15 [32] 0.38
Milk 2 [32] 0.05
Wheat flour 2.8 [32] 0.07
Milk 1 [33] 0.03
Orange juice 10.5 [33] 0.26
a The mushroom powder considered was obtained from P. ostreatus and A. bisporus through UV irradiation as
described in the Material and Methods Section and contained 40 µg/g of vitamin D2.
3.2. The Effect of Mushroom Irradiation on Antioxidant Activity
Considering the variety of mushroom compounds that can act as antioxidants, various extraction
procedures have been proposed to study the antioxidant activity of mushrooms. Comparing the yields
of ethanol and hot water extractions for various mushroom species, it was observed that ethanol
only accounted for 5.89–18.89% of solids, while hot water fraction accounted for 38.3–57.2% of total
solids [34]. Moreover, information obtained by using hot water is considered more valuable because
it corresponds to the procedure used to recover bioactive compounds from medicinal mushrooms
by Chinese traditional medicine [34]. However, studies conducted on P. citrinopileatus have shown a
greater bioactivity in vitro of the cold aqueous extract compared to the hot water extract due to protein
denaturation and degradation of phenolic compounds at high temperatures [24]. Moreover, the ethanol
precipitation of the aqueous extract has been proposed for the isolation of proteoglycans with anticancer
properties [25]. Hence, in the current study, both the cold water extract and ethanol precipitate fractions
of P. ostreatus and A. bisporus were studied to assess the effects of UV irradiation. The water-soluble
fraction of P. ostreatus accounted for 54% of solids, while the ethanol-insoluble fraction was 7.2% of
solids (Table 3). Higher percentage of the water extracts was observed for A. bisporus, i.e., 69%, but the
percentage of ethanol-insoluble fraction was lower, i.e., 3.3% (Table 3). Due to the high extraction yield,
the cold water extracts can be considered representative of the mushroom matrix to investigate the
effect of irradiation on potential bioactive components.
The antioxidant activity in both non-irradiated and UV-irradiated mushrooms was evaluated by
the FC, FRAP and DPPH assays (Table 3).
The levels of FC-reducing compounds for the aqueous extracts of P. ostreatus and A. bisporus before
irradiation were 24.6 and 16.2 mg GAE/g of fraction, respectively. These values can be considered to be
high according to the ranking defined previously in a screening study on 23 species of mushrooms,
which reported levels of FC-reducing compounds of the aqueous extract in the range of from 2 to
37 mg GAE/g [35]. The ethanol-insoluble fractions of both mushrooms showed a higher specific content
of FC-reducing compounds than those of the respective water-soluble fraction for both mushrooms.
This result may suggest that bioactive compounds partitioned mostly into the ethanol-insoluble fraction.
UV irradiation decreased the FC-reducing compounds of P. ostreatus by 20%, while the decrease was
lower for A. bisporus (7%).
The DPPH values for the water extracts of P. ostreatus and A. bisporus before irradiation were
56 and 48 µmol TE/g fraction. As observed for the FC-reducing compounds, the specific DPPH values
for the ethanol-insoluble fractions of both mushrooms were higher than those of the corresponding
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water-soluble fractions. The genusAgaricus has been previously found to have the highest DPPH radical
scavenging properties among the most widely appreciated cultivated mushrooms [36]. UV irradiation
decreased the DPPH values of all fractions, except for the ethanol-insoluble fraction of A. bisporus.
Table 3. Fraction yields and antioxidant activity evaluated by the FC, DPPH and FRAP assays of
the water extracts and ethanol-insoluble fractions of P. ostreatus and A. bisporus before and after UV
irradiation.a.
Mushroom and
Treatment
Fraction
Yield
g/100 g
Antioxidant Activity
FC
mg GAE/g fraction
DPPH
µmol TE/g fraction
FRAP
µmol FeII/g fraction
P. ostreatus WE 54 b ± 3 24.6 c ± 1.3 56 c ± 4 82 d ± 5
P. ostreatus UV WE 54 b ± 3 19.6 d ± 1.5 (20%) 48 d ± 1 (14%) 58 e ± 14 (29%)
A. bisporus WE 67 a ± 1 16.2 e ± 0.5 48 d ± 6 208 b ± 7
A. bisporus UV WE 70 a ± 1 15.0 f ± 0.2 (7%) 37 e ± 7 (23%) 131 c ± 28 (37%)
P. ostreatus EP 7.2 c ± 0.1 32.1 b ± 0.6 71 b ± 1 222 b ± 1
P. ostreatus UV EP 7.3 c ± 0.1 25.8 c ± 0.7 (20%) 49 d ± 3 (31%) 127 c ± 14 (43%)
A. bisporus EP 3.4 d ± 0.1 53.4 a ± 1.6 119 a ± 14 473 a ± 43
A. bisporus UV EP 3.2 d ± 0.1 53.4 a ± 0.8 103 a ± 17 505 a ± 14
aValues are average ± SE; values in brackets are the percent decreases for the UV irradiated samples with
respect to non-irradiated samples. WE = water extract, EP = ethanol precipitate, FC = Folin–Ciocalteu,
DPPH = 2,2-diphenyl-1-(2,4,6 trinitrophenyl)hydrazyl radical, FRAP = ferric ion-reducing antioxidant power,
GAE = gallic acid equivalents, TE = Trolox equivalents. Different letters in the same column (a–e) indicate significant
differences among samples (LSD, p < 0.05).
The FRAP values for the water extracts of P. ostreatus and A. bisporus before irradiation were 82 and
208 µmol FeII/g fraction, respectively. As observed for FC and DPPH, higher specific FRAP values were
present in the ethanol-insoluble fractions than in the water-soluble fractions for both mushroom species,
with values of 222 and 473 µmol FeII/g fraction. This result may be related to the preferential partition
of the bioactive compounds in the ethanol-insoluble fractions. A screening of 1943 plant-based foods
revealed that the average FRAP value is 115.7 µmol FeII/g [37]. Hence, mushrooms can be considered
important as a dietary source of reducing compounds. On the other hand, irradiation caused a marked
decrease in the FRAP values, except for the ethanol-insoluble fraction of A. bisporus.
3.3. The Effect of Mushroom Irradiation on Antiglycation Activity
The antiglycation activity in both non-irradiated and UV-irradiated mushrooms was evaluated by
the BSA/fructose assay (Table 4).
Table 4. Antiglycation activity of the water extracts and ethanol-insoluble fractions of P. ostreatus and
A. bisporus before and after UV irradiation.
Mushroom and
Treatment
Antiglycation Agents
mg AG/g fraction
P. ostreatus WE 113 c ± 22
P. ostreatus UV WE 131 c ± 25
A. bisporus WE 83 d ± 9
A. bisporus UV WE 89 d ± 10
P. ostreatus EP 177 b ± 10
P. ostreatus UV EP 170 b ± 6
A. bisporus EP 555 a ± 80
A. bisporus UV EP 500 a ± 89
Values are average ± SE. WE = water extract, EP = ethanol precipitate, AG = aminoguanidine. Fraction yield
is reported in Table 3. Different letters in the same column (a–d) indicate significant differences among samples
(LSD, p < 0.05).
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The water extracts of P. ostreatus and A. bisporus were able to inhibit protein glycation, exhibiting
113 and 83 mg AG/g fraction. As observed for the antioxidant activity, which was higher in the
ethanol-insoluble fractions, higher levels of antiglycation activity was observed in the ethanol-insoluble
fractions with respect to the water-soluble fractions, corresponding to 177 and 555 mg AG/g fraction
for P. ostreatus and A. bisporus, respectively. There is no information on the antiglycation activity of
these mushroom species. In previous studies, the antiglycation activities of a crude water-soluble
fraction extracted from the sclerotia of Inonotus obliquus [38] and Lignosus rhinocerus [39] were found
to be 23 and 133 mg AG/g fraction. Compared to these latter studies, the antiglycation activities of
the ethanol-insoluble fractions of P. ostreatus and A. bisporus were found to be much higher. However,
even higher antiglycation activity was observed for a polysaccharide purified from the fruiting body
of Boletus snicus, which was found to have the same antiglycation activity of aminoguanidine in the
BSA/glucose model system, i.e., 1000 mg AG/g [40].
The UV irradiation process did not cause any significant change to the antiglycation activity of
P. ostreatus andA. bisporus (Table 4). Despite redox-active compounds generally possessing antiglycation
activity, this activity is also dependent on metal chelation and carbonyl-trapping abilities [16].
4. Conclusions
P. ostreatus and A. bisporus, which are among the most cultivated mushroom species in the world,
were able generate relevant amounts of vitamin D2 through UV irradiation. The concept that this
latter technology can address the global need of vitamin D2 was highlighted by providing a scenario
of possible future application of the vitamin D2 enriched mushroom in target foods. P. ostreatus
and A. bisporus were also found to possess high antioxidant and antiglycation activities. Irradiation
caused a decrease in antioxidant activity in both mushroom species but did not affect antiglycation
activity. The ethanol-insoluble fraction of A. bisporus was not affected by UV irradiation. Results
from this research open up a new area of investigation. In fact, while the relevance of UV irradiation
of mushrooms to address the global need of vitamin D2 has attracted a lot of research interest, the
identification of the effects of irradiation on the mushroom matrices is still lacking and deserves
particular attention.
One limitation of the current study is that it included only two mushroom species. Considering
the wide biodiversity among mushrooms, future studies should be directed to extend knowledge on
the effects of irradiation to other mushroom species in order to assist a more efficient design of the
process for the generation of vitamin D2 with a major focus on the retention of bioactive properties.
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